United Therapeutics Corp at JPMorgan Healthcare Conference Transcript
Good afternoon, everyone. My name is Jess Fye. I'm one of the biotech analysts at JPMorgan. We're continuing the 2020 Healthcare Conference today with United Therapeutics. Quick housekeeping note, we're going to do a Q&A session right after this just down the hall in the Sussex Room. You can follow me there.
But with that, I'll turn it over to the company's CEO, Martine Rothblatt.
Thank you, Jess. Very glad to be here at the JPMorgan 2020 Healthcare Conference. I'm joined today by my colleagues, Michael Benkowitz, President and Chief Operating Officer, to my right; James Edgemond, our Chief Financial Officer, also to my right; Dr. Betsy Eades, our Head of Business Development, to my left; and also Dewey Steadman, our Head of Investor Relations, also to my left. All 5 of us will be available in the breakout room to answer questions afterwards.
I'd like to start with the safe harbor
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |